United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - cilazapril monohydrate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - cilazapril monohydrate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - cilazapril monohydrate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - cilazapril monohydrate - oral tablet - 5mg

Israel - English - Ministry of Health

unipharm ltd, israel - cilazapril; hydrochlorothiazide - tablets - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Canada - English - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 1.0mg - cilazapril (cilazapril monohydrate) 1.0mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 2.5mg - cilazapril (cilazapril monohydrate) 2.5mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 5.0mg - cilazapril (cilazapril monohydrate) 5.0mg - angiotensin-converting enzyme inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg - film coated tablet - 2.5 mg - active: cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg excipient: colloidal silicon dioxide lactose opadry pink 40l14839 pregelatinised maize starch sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 0.522mg equivalent to 0.5 mg cilazapril base - film coated tablet - 0.5 mg - active: cilazapril monohydrate 0.522mg equivalent to 0.5 mg cilazapril base excipient: colloidal silicon dioxide lactose maize starch opadry white y-30-18037 purified water sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.